Candel Therapeutics, Inc. CADL Interest income and other, net
Interest income and other, net at other companies
Other financials
Where this comes from
Reported directly by Candel Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestAndOtherIncome.
The official record: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Candel Therapeutics, Inc.'s interest income and other, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Candel Therapeutics, Inc.'s interest income and other, net?
- Candel Therapeutics, Inc. (CADL) reported interest income and other, net of $1.32M in Q1 2026.
- How has Candel Therapeutics, Inc.'s interest income and other, net changed year-over-year?
- Candel Therapeutics, Inc.'s interest income and other, net increased by 41.5% year-over-year, from $934K to $1.32M.